Suven Life Sciences (SUVEN) — Board Meeting

Suven Life Sciences approved the conversion of 1,85,70,133 fully paid warrants into equity shares at ₹134 per share, allotting the same to 17 non-promoter investors. The company received [amount not verified] in consideration, increasing its paid-up capital from [amount not verified] to [amount not verified]. Additionally, Dr. Vajja Sambasiva Rao was reappointed as an Independent Director for a second term from January 21, 2027, to January 20, 2032, pending shareholder approval at the upcoming AGM. The Board also disclosed plans to incorporate a wholly owned subsidiary in Singapore focused on clinical-stage biopharmaceuticals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUVEN ✨ Ask AI About This

About Suven Life Sciences Limited (SUVEN)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹10,762.81 Cr ROE: -80.9% ROCE: -80.7%

View full SUVEN stock details →

📡 Get AI alerts when SUVEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUVEN — Free

💡 Ask AI about this filing

"How does this board meeting affect Suven Life Sciences Limited's outlook?" "What did Suven Life Sciences Limited announce on 8 July 2026?" "Is this positive or negative for SUVEN?"

Ask AI Free →

📊 More SUVEN filings

See all SUVEN filings →

🔥 Also filed on 8 July 2026

RELIANCE Reliance Industries Limited Announcement RPSGVENT RPSG VENTURES LIMITED Annual Report PRECAM Precision Camshafts Limited Annual Report REFEX Refex Industries Limited Annual Report REFEX Refex Industries Limited Annual Report SBIN State Bank of India Offer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUVEN files new disclosures

Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUVEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd